甲尼达诱导的皮肤不良药物反应 - - 描述性研究的系统审查
Shifa Taj1, Mohammed Zuber2, Vidhyashree Ballagere Hanumanthaiah2
1Department of Pharmacy Practice, Sarada Vilas College of Pharmacy, Mysore, Karnataka, 570001, India.
概括
甲尼达可以引起皮肤反应,固定药物喷发是最常见的. 停止药物和支持性护理有效地管理这些与甲尼达相关的皮肤不良药物反应 (CADRs).
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 甲尼达是一种广泛使用的抗生素和抗原动物药物.
- 皮肤不良药物反应 (CADRs) 是甲尼达治疗的潜在副作用.
- 最近的文献强调了越来越多的研究与甲尼达相关的皮肤症状.
研究的目的:
- 系统地识别和评估对美트로尼达诱导的皮肤表现的描述性研究.
- 分析与这些反应相关的治疗干预和结果.
主要方法:
- 在PubMed,Scopus和灰色文学数据库中进行了全面的文献搜索,截至2022年4月.
- 包括描述性研究,详细介绍了与甲尼达相关的皮肤表现.
- 两名独立审查员进行了研究选择,数据提取和质量评估,第三名审查员解决了差异.
主要成果:
- 综述中包括了24项涉及26名患者的描述性研究.
- 甲尼达用于治疗各种疾病,包括细菌性阴道炎,粉红病和感染.
- 固定药物喷发是最常见的皮肤表现 (7例).
- 随着药物停用和抗组胺剂和局部皮质类固醇等治疗,皮肤症状有所改善.
结论:
- 医疗保健专业人员必须意识到与甲尼达相关的CADR,以防止严重的后果.
- 与支持性治疗相结合的立即中止甲尼达是这些反应的有效管理策略.
相关概念视频
Skin Diseases and Disorders
3.9K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.9K
Pharmacovigilance
916
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
916
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
205
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
205
Drugs for Treatment of Ulcerative Colitis in IBD
181
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
181
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
166
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
166


